---
figid: PMC4128856__cbt-15-1129-g7
figtitle: Targeting c-Met in melanoma
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Danio rerio
- Homo sapiens
pmcid: PMC4128856
filename: cbt-15-1129-g7.jpg
figlink: /pmc/articles/PMC4128856/figure/F7/
number: F7
caption: Figure 7.  Proposed role of mTOR and Wnt pathways in c-Met inhibitor resistance.
  Increased resistance to c-Met inhibitors could be due to overexpression of c-Met
  and consequent activation of c-Met-dependent PI3K/Akt/mTOR, RAS/RAF/MEK/ERK (MAPK)
  or alternative signaling pathways, such as the Wnt pathway. Upregulation of the
  Akt/mTOR pathway in c-Met TKI resistant cells leads to increased cell survival and
  proliferation. Furthermore, we postulate that in c-Met resistant cells, phosphorylation
  of ERK by the RAS/RAF pathway may lead to phosphorylation of GATA-6. Upregulated
  GATA-6 () also stimulates the Wnt pathway, which may result in accumulation of β-catenin
  in the nucleus, leading to melanoma tumorigenicity.
papertitle: Targeting c-Met in melanoma.
reftext: Deven Etnyre, et al. Cancer Biol Ther. 2014 Sep 1;15(9):1129-1141.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.970764
figid_alias: PMC4128856__F7
figtype: Figure
redirect_from: /figures/PMC4128856__F7
ndex: 00e081ad-dec8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4128856__cbt-15-1129-g7.html
  '@type': Dataset
  description: Figure 7.  Proposed role of mTOR and Wnt pathways in c-Met inhibitor
    resistance. Increased resistance to c-Met inhibitors could be due to overexpression
    of c-Met and consequent activation of c-Met-dependent PI3K/Akt/mTOR, RAS/RAF/MEK/ERK
    (MAPK) or alternative signaling pathways, such as the Wnt pathway. Upregulation
    of the Akt/mTOR pathway in c-Met TKI resistant cells leads to increased cell survival
    and proliferation. Furthermore, we postulate that in c-Met resistant cells, phosphorylation
    of ERK by the RAS/RAF pathway may lead to phosphorylation of GATA-6. Upregulated
    GATA-6 () also stimulates the Wnt pathway, which may result in accumulation of
    β-catenin in the nucleus, leading to melanoma tumorigenicity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Wnt5
  - Wnt4
  - wg
  - Wnt2
  - arr
  - fz
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Axn
  - dsh
  - ras
  - Ras64B
  - Ras85D
  - Akt
  - sgg
  - Raf
  - arm
  - gig
  - Dsor1
  - Mtk
  - Rheb
  - Erk7
  - rl
  - Mtor
  - Tor
  - Thor
  - S6k
  - pan
  - Apc
  - Apc2
  - Fs(3)Apc
  - lrp5
  - lrp6
  - rab1ab
  - gsk3ba
  - gsk3ab
  - tsc2
  - rheb
  - rhebl1
  - mtor
  - gata6
  - apc
  - HGF
  - IL6
  - SOS1
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - LRP5
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AXIN1
  - AXIN2
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - IFT81
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - GSK3A
  - GSK3B
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - TSC2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - RHEB
  - RHEBP1
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - GATA6
  - EIF4EBP1
  - RPS6KB1
  - APC
  - PROC
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
